G1 Therapeutics | 4:持股變動聲明-董事 Lee Jacks
G1 Therapeutics | 4:持股變動聲明-董事 Flowers Cynthia Louise
G1 Therapeutics | 4:持股變動聲明-董事 Secor Alicia
G1 Therapeutics | 4:持股變動聲明-董事 Sharpless Norman
G1 Therapeutics | 4:持股變動聲明-董事 MUIR GLENN P
G1 Therapeutics | 4:持股變動聲明-董事 Nicholson Garry A
G1 Therapeutics | 4:持股變動聲明-高管 Thomas Monica R.
G1 Therapeutics | 4:持股變動聲明-高管 Perry Andrew
G1 Therapeutics | 4:持股變動聲明-高管 MURDOCK TERRY L
G1 Therapeutics | 4:持股變動聲明-高管 Bailey John E. (Jack) Jr.
G1 Therapeutics | 4:持股變動聲明-高管 Malik Rajesh
G1 Therapeutics | 4:持股變動聲明-高管 Umstead John W. V
G1 Therapeutics | 4:持股變動聲明-高管 Avagliano Mark
G1 Therapeutics | 4:持股變動聲明-高管 Avagliano Mark
G1 Therapeutics | 4:持股變動聲明-高管 Thomas Monica R.
G1 Therapeutics | 4:持股變動聲明-高管 Umstead John W. V
G1 Therapeutics | 4:持股變動聲明-高管 Umstead John W. V
G1 Therapeutics | SC 13D/A:超過5%持股股東披露文件(修正)-Fredric N. Eshelman(9.26%),Eshelman Ventures, LLC(8.13%)
G1 Therapeutics | 4:持股變動聲明-高管 Malik Rajesh
G1 Therapeutics | 4:持股變動聲明-高管 Umstead John W. V
暫無數據